ZTS(Zoetis Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $7.78B | $8.08B | $8.54B | $9.26B | $9.47B |
| 毛利润 | $5.47B | $5.63B | $5.98B | $6.54B | $6.80B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $2.04B | $2.11B | $2.34B | $2.49B | $2.67B |
| 经营现金流 | $2.21B | $1.91B | $2.35B | $2.95B | $2.90B |
| 自由现金流 | $1.74B | $1.33B | $1.62B | $2.30B | $2.28B |
| 摊薄每股收益 | $4.27 | $4.49 | $5.07 | $5.47 | $6.02 |